CVE:AQS Aequus Pharmaceuticals (AQS) Stock Price, News & Analysis C$0.01 -0.01 (-33.33%) (As of 10/15/2024) Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsInsider Trades About Aequus Pharmaceuticals Stock (CVE:AQS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aequus Pharmaceuticals alerts:Sign Up Key Stats Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0352-Week RangeC$0.01▼C$0.05Volume9,705 shsAverage Volume179,324 shsMarket CapitalizationC$1.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.Read More… New gold frenzy underway (Ad)Gold: Now legal tender Most Americans missed this big story, but 1 in 5 states have now made gold and silver coins legal tender. It's just one reason why so many predict gold will soon hit $5,000. And why you need to check out this $6 strategy for gold immediately.Click here for full details. Receive AQS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address AQS Stock News HeadlinesAequus Pharmaceuticals Inc. (AQSZF)September 5, 2024 | finance.yahoo.comAequus Pharmaceuticals Inc (AQS)August 3, 2024 | investing.comNew gold frenzy underwayGold: Now legal tender Most Americans missed this big story, but 1 in 5 states have now made gold and silver coins legal tender. It's just one reason why so many predict gold will soon hit $5,000. And why you need to check out this $6 strategy for gold immediately.October 21, 2024 | Stansberry Research (Ad)Closing Bell: Aequus Pharmaceuticals Inc down on Friday (AQS)July 23, 2024 | theglobeandmail.comAequus Pharmaceuticals Full Year 2023 Earnings: CA$0.022 loss per share (vs CA$0.024 loss in FY 2022)May 2, 2024 | finance.yahoo.comAQS:CA Aequus Pharmaceuticals Inc.April 20, 2024 | seekingalpha.comZoomd Technologies: Top 10 Undervalued Growth Stocks on TSX-V (ZOMD)February 23, 2024 | theglobeandmail.comAequus Pharmaceuticals: Top 10 Undervalued Drug Manufacturers Industry Stocks (AQS)February 18, 2024 | theglobeandmail.comSee More Headlines AQS Stock Analysis - Frequently Asked Questions How have AQS shares performed this year? Aequus Pharmaceuticals' stock was trading at C$0.03 at the beginning of the year. Since then, AQS stock has decreased by 60.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. How were Aequus Pharmaceuticals' earnings last quarter? Aequus Pharmaceuticals Inc. (CVE:AQS) issued its earnings results on Thursday, August, 29th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.16 million for the quarter. How do I buy shares of Aequus Pharmaceuticals? Shares of AQS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Aequus Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aequus Pharmaceuticals investors own include GrowLife (PHOT), Unrivaled Brands (TRTC), Acorn Energy (ACFN), Crown Castle (CCI), LiCo Energy Metals (LIC), Marijuana Company of America (MCOA) and Rogers (ROG). Company Calendar Last Earnings8/29/2024Today10/21/2024Next Earnings (Estimated)12/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:AQS CUSIPN/A CIKN/A Webwww.aequuspharma.ca Phone+1-604-3367906FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,860,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-1,569.60% Return on Assets-178.79% Debt Debt-to-Equity Ratio138.88 Current Ratio0.07 Quick Ratio0.46 Sales & Book Value Annual SalesC$1.17 million Price / Sales1.13 Cash FlowC$0.00 per share Price / Cash Flow5.00 Book ValueC($0.04) per share Price / Book-0.25Miscellaneous Outstanding Shares132,630,000Free FloatN/AMarket CapC$1.33 million OptionableNot Optionable Beta-0.02 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report This page (CVE:AQS) was last updated on 10/21/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredAfter calling a 2,269% gain, here’s his NEXT tradeReady for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredCostco gold maniaIs Gold Headed Above $3,000 per Ounce? Here's How to Play It… With so many strange events happening across ...Stansberry Research | SponsoredNotice: Major payout due November 19th - are you on the list?On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's p...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored[SHOCKING] Crypto Document Leak…The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aequus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aequus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.